Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

DATA COMPILATION
#PharmaFlow

Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

Stock Recap
#PipelineProspector

Alapren

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

50 API Suppliers, 18 USDMF, 12 CEP/COS, 4 JDMF, 1 EU WC, 10 KDMF, 11 NDC API, 18 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

10 Drugs in Development

10 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

921 FDF Dossiers, 94 FDA Orange Book, 597 Europe, 46 Canada, 42 Australia, 49 South Africa, 93 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 2.5MG, TABLET;ORAL - 20MG, TABLET;ORAL - 5MG, TABLET;ORAL - 10MG;25MG, TABLET;ORAL - 5MG;12.5MG, FOR SOLUTION;ORAL - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 5 SPI Pharma, 1 Pharm-RX Chemical, 5 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 4 Kirsch Pharma, 7 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 2 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 10 Corel Pharma Chem, 6 DFE Pharma, 6 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 24 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Fillers, Diluents & Binders, 41 Coating Systems & Additives, 28 Direct Compression, 25 Granulation, 20 Lubricants & Glidants, 16 Thickeners and Stabilizers, 16 Controlled & Modified Release, 16 Disintegrants & Superdisintegrants, 12 Taste Masking, 11 Co-Processed Excipients, 10 API Stability Enhancers, 8 Chewable & Orodispersible Aids, 8 Film Formers & Plasticizers, 5 Parenteral, 5 Empty Capsules, 5 Emulsifying Agents, 4 Vegetarian Capsules, 3 Rheology Modifiers, 3 Topical, 2 Coloring Agents, 1 Surfactant & Foaming Agents, 1 Solubilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 30 News #PharmaBuzz

GLOBAL SALES INFORMATION

18 US Medicaid Prescriptions, 195 Regulatory FDF Prices

MARKET PLACE

24 APIs, 12 FDF Dossiers

PATENTS & EXCLUSIVITIES

29 US Patents

29 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 3 JP, 6 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Labeler	NDC Package Code	Non Proprietary Name	Start Marketing Date	End Marketing Date	Category Code	Dosage Form (Strength)
31/03/2026	Aarti Pharmalabs	India	Aarti Pharmalabs Limited	15308-2601	Enalapril Maleate	2025-03-03	2027-12-31	BULK INGREDIENT	POWDER (1kg/kg)
31/03/2026	Neuland Laboratories	India	Neuland Laboratories Limited	58032-0125	Enalapril Maleate	2017-11-27	2026-12-31	BULK INGREDIENT	POWDER (1kg/kg)

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Alapren

Alapren

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

50 API Suppliers

18 USDMF

12 CEP/COS

4 JDMF

1 EU WC

10 KDMF

11 NDC API

18 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

10 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

921 FDF Dossiers

94 FDA Orange Book

597 Europe

46 Canada

42 Australia

49 South Africa

93 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG

TABLET;ORAL - 2.5MG

TABLET;ORAL - 20MG

TABLET;ORAL - 5MG

TABLET;ORAL - 10MG;25MG

TABLET;ORAL - 5MG;12.5MG

FOR SOLUTION;ORAL - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

5 SPI Pharma

1 Pharm-RX Chemical

5 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

4 Kirsch Pharma

7 Dr. Paul Lohmann GmbH & Co. KGaA

1 ACG Worldwide

2 Actylis

1 Aeon Procare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

9 BASF

1 Bioplus Life Sciences

1 CD Formulation

10 Corel Pharma Chem

6 DFE Pharma

6 Gangwal Chemicals

4 Ideal Cures

3 Ingredion Pharma Solutions

24 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

13 Microlex e.U

2 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

1 Novo Excipients

1 Pharmatrans-Sanaq

6 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

18 Roquette

7 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

10 Sigachi Industries

3 Silverline Chemicals

2 The Dow Chemical Company

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Fillers, Diluents & Binders

41 Coating Systems & Additives

28 Direct Compression

25 Granulation

FOR SOLUTION;ORAL - 1MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons